Cellular senescence throws new insights into patient classification and pharmacological interventions for clinical management of hepatocellular carcinoma

Figure 9 Experimental verification of expression of TRNP1 in hepatocellular carcinomas. A and B: Representative immunohistochemistry of TRNP1 expression in human hepatocellular carcinomas (HCCs) and normal tissues. Bar, 50 μm; C and D: Representative immunoblotting of TRNP1 expression in human HCCs and normal tissues; E: Quantitative real-time polymerase chain reaction of TRNP1 expression in 30 pairs of human HCCs and normal tissues; F–H: Immunoblotting of TRNP1 expression in SMMC-7721 and HepG2 cells transfected with specific siRNAs of TRNP1. ^cP < 0.001; ^dP < 0.0001.